Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
TCR2 Therapeutics Inc.:
We consent to the use of our report included herein and to the reference to our firm under the heading “Experts” in the prospectus.
(signed) KPMG LLP
Cambridge, Massachusetts
December 28, 2018
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.
